At EmVenio, we understand that the start-up phase of a clinical trial can often be a time-consuming process (not to mention the years of development before the trial can begin). However, we are proud to share that our team has been able to shorten the timelines for a recent study to 36 days. By leveraging our established sites and expertise in the field, we were able to successfully streamline the start-up procedure, allowing for a more efficient and expedited process.

This can allow Sponsors to begin their clinical trials sooner, ultimately benefiting patients and bringing potentially life-saving treatments to market faster. 

Partner with us to accelerate your study.